tm logo
AVERITAS PHARMA
Live/Registered
REGISTERED

on 15 Aug 2023

Last Applicant/ Owned by

360 Mount Kemble Ave.

Morristown

NJ

07960

Serial Number

97381272 filed on 26th Apr 2022

Registration Number

7136344 registered on 15th Aug 2023

in the Principal Register

Correspondent Address

Paul C. Llewellyn

Paul C. Llewellyn

250 WEST 55TH STREET

NEW YORK NY 10019-9710

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

AVERITAS PHARMA

Medical services, namely, providing and supplying of information in the healthcare field of pain treatment; providing website portals on the internet featuring information in the healthcare field of pain treatment; providing content retrievable via the internet, namely, providing information in the healthcare field of pain treatment

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical services, namely, providing and supplying of information in the healthcare field of pain treatment; providing website portals on the internet featuring information in the healthcare field of pain treatment; providing content retrievable via the internet, namely, providing information in the healthcare field of pain treatment


First Use Date in General

07th May 2021

First Use Date in Commerce

07th May 2021

Specimens


AVERITAS PHARMA specimenAVERITAS PHARMA specimenAVERITAS PHARMA specimen

Mark Details


Serial Number

No 97381272

Mark Type

No Service Mark

Attorney Docket Number

No 1101804-0002

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
15th Aug 2023REGISTERED-PRINCIPAL REGISTER
15th Aug 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
30th May 2023PUBLISHED FOR OPPOSITION
30th May 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10th May 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21st Apr 2023APPROVED FOR PUB - PRINCIPAL REGISTER
13th Apr 2023TEAS/EMAIL CORRESPONDENCE ENTERED
12th Apr 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
12th Apr 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
15th Feb 2023NON-FINAL ACTION WRITTEN